⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MLTX News
MoonLake Immunotherapeutics Class A Ordinary Shares
SueWallSt Podcast Series Launches With Focus on MoonLake Immunotherapeutics (MLTX) Fraud Allegations
accessnewswire.com
MLTX
Class Action Lawsuit Filed: MoonLake Immunotherapeutics (MLTX) - Join by December 15, 2025 - Contact Levi & Korsinsky
accessnewswire.com
MLTX
MLTX SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that MoonLake Immunotherapeutics Stockholders with Losses Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
MLTX
Pomerantz LLP Alerts Shareholders to Investor Suit Filed Against MoonLake Immunotherapeutics – MLTX
accessnewswire.com
MLTX
MLTX Investors Have Opportunity to Lead MoonLake Immunotherapeutics Securities Fraud Lawsuit with the Schall Law Firm
prnewswire.com
MLTX
Contact Levi & Korsinsky by December 15, 2025 to Join Class Action Against MoonLake Immunotherapeutics (MLTX)
accessnewswire.com
MLTX
MoonLake Immunotherapeutics Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - MLTX
prnewswire.com
MLTX
Levi & Korsinsky Notifies MoonLake Immunotherapeutics (MLTX) Investors - Lead Plaintiff Deadline on December 15, 2025
accessnewswire.com
MLTX
Levi & Korsinsky Notifies MoonLake Immunotherapeutics (MLTX) Investors - Lead Plaintiff Deadline on December 15, 2025
accessnewswire.com
MLTX
Pomerantz LLP Calls Attention to Class Action Against MoonLake Immunotherapeutics – MLTX
accessnewswire.com
MLTX